 | • レポートコード：QFJ1-4344 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、特発性頭蓋内圧亢進症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アセタゾラミド、フロセミド、トピラメート、オクトレオチド）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・特発性頭蓋内圧亢進症治療薬の市場動向 ・企業の競争状況、市場シェア ・特発性頭蓋内圧亢進症治療薬の種類別市場規模と予測2016-2027（アセタゾラミド、フロセミド、トピラメート、オクトレオチド） ・特発性頭蓋内圧亢進症治療薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、その他） ・特発性頭蓋内圧亢進症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・特発性頭蓋内圧亢進症治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・特発性頭蓋内圧亢進症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・特発性頭蓋内圧亢進症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・特発性頭蓋内圧亢進症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie、Astellas Pharma、Cadila Healthcare、Johnson & Johnson Services、Merck、Mylan、Pfizer、Sanofi、Sun Pharmaceutical、Teva Pharmaceutical） ・結論 |
A drug used to treat idiopathic intracranial hypertension.
Market Analysis and Insights: Global Idiopathic Intracranial Hypertension Therapeutics Market
The global Idiopathic Intracranial Hypertension Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Idiopathic Intracranial Hypertension Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Idiopathic Intracranial Hypertension Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Idiopathic Intracranial Hypertension Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Idiopathic Intracranial Hypertension Therapeutics market.
Global Idiopathic Intracranial Hypertension Therapeutics Scope and Market Size
Idiopathic Intracranial Hypertension Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Idiopathic Intracranial Hypertension Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Acetazolamide
Furosemide
Topiramate
Octreotide
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AbbVie
Astellas Pharma
Cadila Healthcare
Johnson & Johnson Services
Merck
Mylan
Pfizer
Sanofi
Sun Pharmaceutical
Teva Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Idiopathic Intracranial Hypertension Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Acetazolamide
1.2.3 Furosemide
1.2.4 Topiramate
1.2.5 Octreotide
1.3 Market by Application
1.3.1 Global Idiopathic Intracranial Hypertension Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Idiopathic Intracranial Hypertension Therapeutics Market Perspective (2016-2027)
2.2 Idiopathic Intracranial Hypertension Therapeutics Growth Trends by Regions
2.2.1 Idiopathic Intracranial Hypertension Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Idiopathic Intracranial Hypertension Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Idiopathic Intracranial Hypertension Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Idiopathic Intracranial Hypertension Therapeutics Industry Dynamic
2.3.1 Idiopathic Intracranial Hypertension Therapeutics Market Trends
2.3.2 Idiopathic Intracranial Hypertension Therapeutics Market Drivers
2.3.3 Idiopathic Intracranial Hypertension Therapeutics Market Challenges
2.3.4 Idiopathic Intracranial Hypertension Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Idiopathic Intracranial Hypertension Therapeutics Players by Revenue
3.1.1 Global Top Idiopathic Intracranial Hypertension Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Idiopathic Intracranial Hypertension Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Idiopathic Intracranial Hypertension Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Idiopathic Intracranial Hypertension Therapeutics Revenue
3.4 Global Idiopathic Intracranial Hypertension Therapeutics Market Concentration Ratio
3.4.1 Global Idiopathic Intracranial Hypertension Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Idiopathic Intracranial Hypertension Therapeutics Revenue in 2020
3.5 Idiopathic Intracranial Hypertension Therapeutics Key Players Head office and Area Served
3.6 Key Players Idiopathic Intracranial Hypertension Therapeutics Product Solution and Service
3.7 Date of Enter into Idiopathic Intracranial Hypertension Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Idiopathic Intracranial Hypertension Therapeutics Breakdown Data by Type
4.1 Global Idiopathic Intracranial Hypertension Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Idiopathic Intracranial Hypertension Therapeutics Forecasted Market Size by Type (2022-2027)
5 Idiopathic Intracranial Hypertension Therapeutics Breakdown Data by Application
5.1 Global Idiopathic Intracranial Hypertension Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Idiopathic Intracranial Hypertension Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Idiopathic Intracranial Hypertension Therapeutics Market Size (2016-2027)
6.2 North America Idiopathic Intracranial Hypertension Therapeutics Market Size by Type
6.2.1 North America Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2016-2027)
6.3 North America Idiopathic Intracranial Hypertension Therapeutics Market Size by Application
6.3.1 North America Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2016-2027)
6.4 North America Idiopathic Intracranial Hypertension Therapeutics Market Size by Country
6.4.1 North America Idiopathic Intracranial Hypertension Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Idiopathic Intracranial Hypertension Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Idiopathic Intracranial Hypertension Therapeutics Market Size (2016-2027)
7.2 Europe Idiopathic Intracranial Hypertension Therapeutics Market Size by Type
7.2.1 Europe Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2016-2027)
7.3 Europe Idiopathic Intracranial Hypertension Therapeutics Market Size by Application
7.3.1 Europe Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2016-2027)
7.4 Europe Idiopathic Intracranial Hypertension Therapeutics Market Size by Country
7.4.1 Europe Idiopathic Intracranial Hypertension Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Idiopathic Intracranial Hypertension Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Size by Type
8.2.1 Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Size by Application
8.3.1 Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Size by Region
8.4.1 Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Idiopathic Intracranial Hypertension Therapeutics Market Size (2016-2027)
9.2 Latin America Idiopathic Intracranial Hypertension Therapeutics Market Size by Type
9.2.1 Latin America Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Idiopathic Intracranial Hypertension Therapeutics Market Size by Application
9.3.1 Latin America Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Idiopathic Intracranial Hypertension Therapeutics Market Size by Country
9.4.1 Latin America Idiopathic Intracranial Hypertension Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Idiopathic Intracranial Hypertension Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Size by Type
10.2.1 Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Size by Application
10.3.1 Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Size by Country
10.4.1 Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Idiopathic Intracranial Hypertension Therapeutics Introduction
11.1.4 AbbVie Revenue in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Details
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Idiopathic Intracranial Hypertension Therapeutics Introduction
11.2.4 Astellas Pharma Revenue in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021)
11.2.5 Astellas Pharma Recent Development
11.3 Cadila Healthcare
11.3.1 Cadila Healthcare Company Details
11.3.2 Cadila Healthcare Business Overview
11.3.3 Cadila Healthcare Idiopathic Intracranial Hypertension Therapeutics Introduction
11.3.4 Cadila Healthcare Revenue in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021)
11.3.5 Cadila Healthcare Recent Development
11.4 Johnson & Johnson Services
11.4.1 Johnson & Johnson Services Company Details
11.4.2 Johnson & Johnson Services Business Overview
11.4.3 Johnson & Johnson Services Idiopathic Intracranial Hypertension Therapeutics Introduction
11.4.4 Johnson & Johnson Services Revenue in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021)
11.4.5 Johnson & Johnson Services Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Idiopathic Intracranial Hypertension Therapeutics Introduction
11.5.4 Merck Revenue in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Mylan Business Overview
11.6.3 Mylan Idiopathic Intracranial Hypertension Therapeutics Introduction
11.6.4 Mylan Revenue in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021)
11.6.5 Mylan Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Idiopathic Intracranial Hypertension Therapeutics Introduction
11.7.4 Pfizer Revenue in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Idiopathic Intracranial Hypertension Therapeutics Introduction
11.8.4 Sanofi Revenue in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Sun Pharmaceutical
11.9.1 Sun Pharmaceutical Company Details
11.9.2 Sun Pharmaceutical Business Overview
11.9.3 Sun Pharmaceutical Idiopathic Intracranial Hypertension Therapeutics Introduction
11.9.4 Sun Pharmaceutical Revenue in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021)
11.9.5 Sun Pharmaceutical Recent Development
11.10 Teva Pharmaceutical
11.10.1 Teva Pharmaceutical Company Details
11.10.2 Teva Pharmaceutical Business Overview
11.10.3 Teva Pharmaceutical Idiopathic Intracranial Hypertension Therapeutics Introduction
11.10.4 Teva Pharmaceutical Revenue in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021)
11.10.5 Teva Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Idiopathic Intracranial Hypertension Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Acetazolamide
Table 3. Key Players of Furosemide
Table 4. Key Players of Topiramate
Table 5. Key Players of Octreotide
Table 6. Global Idiopathic Intracranial Hypertension Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Idiopathic Intracranial Hypertension Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Idiopathic Intracranial Hypertension Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Idiopathic Intracranial Hypertension Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Idiopathic Intracranial Hypertension Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Idiopathic Intracranial Hypertension Therapeutics Market Share by Regions (2022-2027)
Table 12. Idiopathic Intracranial Hypertension Therapeutics Market Trends
Table 13. Idiopathic Intracranial Hypertension Therapeutics Market Drivers
Table 14. Idiopathic Intracranial Hypertension Therapeutics Market Challenges
Table 15. Idiopathic Intracranial Hypertension Therapeutics Market Restraints
Table 16. Global Idiopathic Intracranial Hypertension Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Idiopathic Intracranial Hypertension Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Idiopathic Intracranial Hypertension Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Idiopathic Intracranial Hypertension Therapeutics as of 2020)
Table 19. Ranking of Global Top Idiopathic Intracranial Hypertension Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Idiopathic Intracranial Hypertension Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Idiopathic Intracranial Hypertension Therapeutics Product Solution and Service
Table 23. Date of Enter into Idiopathic Intracranial Hypertension Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Idiopathic Intracranial Hypertension Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Idiopathic Intracranial Hypertension Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Idiopathic Intracranial Hypertension Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Idiopathic Intracranial Hypertension Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Idiopathic Intracranial Hypertension Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Idiopathic Intracranial Hypertension Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Idiopathic Intracranial Hypertension Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Idiopathic Intracranial Hypertension Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Idiopathic Intracranial Hypertension Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Idiopathic Intracranial Hypertension Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Idiopathic Intracranial Hypertension Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Idiopathic Intracranial Hypertension Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Idiopathic Intracranial Hypertension Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. AbbVie Company Details
Table 64. AbbVie Business Overview
Table 65. AbbVie Idiopathic Intracranial Hypertension Therapeutics Product
Table 66. AbbVie Revenue in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021) & (US$ Million)
Table 67. AbbVie Recent Development
Table 68. Astellas Pharma Company Details
Table 69. Astellas Pharma Business Overview
Table 70. Astellas Pharma Idiopathic Intracranial Hypertension Therapeutics Product
Table 71. Astellas Pharma Revenue in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Astellas Pharma Recent Development
Table 73. Cadila Healthcare Company Details
Table 74. Cadila Healthcare Business Overview
Table 75. Cadila Healthcare Idiopathic Intracranial Hypertension Therapeutics Product
Table 76. Cadila Healthcare Revenue in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Cadila Healthcare Recent Development
Table 78. Johnson & Johnson Services Company Details
Table 79. Johnson & Johnson Services Business Overview
Table 80. Johnson & Johnson Services Idiopathic Intracranial Hypertension Therapeutics Product
Table 81. Johnson & Johnson Services Revenue in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Johnson & Johnson Services Recent Development
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Idiopathic Intracranial Hypertension Therapeutics Product
Table 86. Merck Revenue in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Merck Recent Development
Table 88. Mylan Company Details
Table 89. Mylan Business Overview
Table 90. Mylan Idiopathic Intracranial Hypertension Therapeutics Product
Table 91. Mylan Revenue in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Mylan Recent Development
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer Idiopathic Intracranial Hypertension Therapeutics Product
Table 96. Pfizer Revenue in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Pfizer Recent Development
Table 98. Sanofi Company Details
Table 99. Sanofi Business Overview
Table 100. Sanofi Revenue in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021) & (US$ Million)
Table 101. Sanofi Recent Development
Table 102. Sun Pharmaceutical Company Details
Table 103. Sun Pharmaceutical Business Overview
Table 104. Sun Pharmaceutical Idiopathic Intracranial Hypertension Therapeutics Product
Table 105. Sun Pharmaceutical Revenue in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021) & (US$ Million)
Table 106. Sun Pharmaceutical Recent Development
Table 107. Teva Pharmaceutical Company Details
Table 108. Teva Pharmaceutical Business Overview
Table 109. Teva Pharmaceutical Idiopathic Intracranial Hypertension Therapeutics Product
Table 110. Teva Pharmaceutical Revenue in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021) & (US$ Million)
Table 111. Teva Pharmaceutical Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Idiopathic Intracranial Hypertension Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Acetazolamide Features
Figure 3. Furosemide Features
Figure 4. Topiramate Features
Figure 5. Octreotide Features
Figure 6. Global Idiopathic Intracranial Hypertension Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Other Case Studies
Figure 10. Idiopathic Intracranial Hypertension Therapeutics Report Years Considered
Figure 11. Global Idiopathic Intracranial Hypertension Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Idiopathic Intracranial Hypertension Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Idiopathic Intracranial Hypertension Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Idiopathic Intracranial Hypertension Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Idiopathic Intracranial Hypertension Therapeutics Market Share by Players in 2020
Figure 16. Global Top Idiopathic Intracranial Hypertension Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Idiopathic Intracranial Hypertension Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Idiopathic Intracranial Hypertension Therapeutics Revenue in 2020
Figure 18. Global Idiopathic Intracranial Hypertension Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Idiopathic Intracranial Hypertension Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Idiopathic Intracranial Hypertension Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Idiopathic Intracranial Hypertension Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Idiopathic Intracranial Hypertension Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Idiopathic Intracranial Hypertension Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Idiopathic Intracranial Hypertension Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Idiopathic Intracranial Hypertension Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Idiopathic Intracranial Hypertension Therapeutics Market Share by Region (2016-2027)
Figure 40. China Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Idiopathic Intracranial Hypertension Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Idiopathic Intracranial Hypertension Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Idiopathic Intracranial Hypertension Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Idiopathic Intracranial Hypertension Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Idiopathic Intracranial Hypertension Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AbbVie Revenue Growth Rate in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021)
Figure 60. Astellas Pharma Revenue Growth Rate in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021)
Figure 61. Cadila Healthcare Revenue Growth Rate in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021)
Figure 62. Johnson & Johnson Services Revenue Growth Rate in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021)
Figure 64. Mylan Revenue Growth Rate in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021)
Figure 67. Sun Pharmaceutical Revenue Growth Rate in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021)
Figure 68. Teva Pharmaceutical Revenue Growth Rate in Idiopathic Intracranial Hypertension Therapeutics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の特発性過眠症治療市場規模・現状・予測（2021年-2027年） Idiopathic hypersomnia (IH) is a rare sleep disorder marked by an over sleeping duration time during the day even after a longer sleeping hours of night sleep. People with idiopathic hypersomnia sleep normal or for long hours each night but still feel excessively sleepy during the day. Idiopathic hy…- 世界のICAD (頭蓋内アテローム性動脈硬化症) 病理学治療市場規模・現状・予測（2021年-2027年） Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that …
- 世界の脳動脈瘤治療市場規模・現状・予測（2021年-2027年） Intracranial aneurysm, also known as brain or cerebral aneurysm, is a bulging, weakened area in the wall of an artery in the brain. It results in an abnormal ballooning, widening, or bleb. An intracranial aneurysm majorly occurs in an artery located in the front part of the brain, which supplies oxy…
- 世界の高血圧＆心不全治療薬市場規模・現状・予測（2021年-2027年） Hypertension and Heart Failure Drugs such as β-blockers, angiotensin-converting enzyme inhibitiors, angiotensin receptor blockers, aldosterone receptor blockers, hydralazine and nitrates, which have shown mortality benefit in CHF and exert antihypertensive effects, are used as first-line agents to c…
- 世界の特発性肺線維症治療市場規模・現状・予測（2021年-2027年） Idiopathic Pulmonary Fibrosis Treatment is treatment work on a lung disease which causes the tissue in your lungs to become stiff. Market Analysis and Insights: Global Idiopathic Pulmonary Fibrosis Treatment Market The global Idiopathic Pulmonary Fibrosis Treatment market size is projected to reach…